<- Go Home
AmpliPhi Biosciences Corporation
As of May 9, 2019, was acquired by C3J Therapeutics, Inc., in a reverse merger transaction.
Market Cap
$11.1M
Volume
25.7K
Cash and Equivalents
$5.5M
EBITDA
-$10.7M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
-$4.9M
Profit Margin
N/A
52 Week High
$19.18
52 Week Low
$2.15
Dividend
N/A
Price / Book Value
2.19
Price / Earnings
-0.63
Price / Tangible Book Value
5.46
Enterprise Value
N/A
Enterprise Value / EBITDA
N/A
Operating Income
-$11.1M
Return on Equity
154.98%
Return on Assets
-58.01
Cash and Short Term Investments
$5.5M
Debt
N/A
Equity
$5.0M
Revenue
N/A
Unlevered FCF
-$4.2M
Sector
Biotechnology
Category
N/A